← Every company
Catalent Inc Patents
What Catalent Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
CTLT on carbonthat →Filings on file
11
Granted
0
Still pending
11
Filed under
6 names
11 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| PHARMACEUTICAL FORMULATIONS OF NAPROXEN FOR SOFT GEL ENCAPSULATION AND COMBINATIONS THEREOFA61K 9/4833, A61K 31/192, A61P 29/00, A61K 9/0053, A61K 9/48, A61K 9/4858, A61K 9/4866, A61K 45/06, A61K2300/00Filed as Catalent Ontario Limited2026-03-20John Lopez | pending |
| METHODS OF PREPARING MULTIPHASE STATIN AND OMEGA-3 FATTY ACID SOFT CAPSULE FORMULATIONSA61K 9/5084, A61P 43/00, A61P 3/06Filed as Catalent Ontario Limited2026-01-21Peter Draper | pending |
| MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOFFiled as Catalent Ontario Limited2025-12-05Soo Ah Jin | pending |
| PHARMACEUTICAL COMPOSITIONS USING NON-ANIMAL ORIGIN MATRIX FORMERS AND METHODS OF MAKING THEREOFA61K 9/0056, A61K 47/38, A61K 9/1694, A61K 9/19, A61K 9/2018, A61K 9/2054, A61K 31/192, A61K 31/198, A61K 31/4545, A61K 47/26, A61K 47/36Filed as Catalent U.K. Swindon Zydis Limited2025-11-13Malgorzata KLETA | pending |
| VECTORS FOR PROTEIN MANUFACTUREC12N 15/86, C12P 21/02, A61K 48/00, C07H 21/02, C07H 21/04, C07K2319/30, C12N 15/85, C12N2740/10043, C12N2740/13043Filed as CATALENT PHARMA SOLUTIONS, LLC2024-11-21Gregory T. Bleck | pending |
| PHARMACEUTICAL COMPOSITIONS USING NON-ANIMAL ORIGIN MATRIX FORMERS AND METHODS OF MAKING THEREOFFiled as Catalent U.K. Swindon Zydis Limited2024-11-14Malgorzata KLETA | pending |
| LIQUID FORMULATIONS OF IVERMECTIN COMPOSITIONS AND USE IN GELATIN DOSAGE FORMSA61K 31/7048, A61P 25/08, A61K 9/4825, A61K 9/4858, A61K 31/23, A61K 31/355, A61K 47/14, A61K 47/22, A61K 47/26, A61K2300/00Filed as Catalent Pharma Solutions, LLC2024-09-20Samuel D. Waksal | pending |
| DNASE CO-EXPRESSION IN HOST CELLSFiled as CATALENT PHARMA SOLUTIONS, LLC2024-08-30GREGORY BLECK | pending |
| MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOFFiled as CATALENT ONTARIO LIMITED2024-06-04SOO AH JIN | pending |
| INCREASING PERMEATION FOR PRE-GASTRIC ABSORPTION OF ACTIVE PHARMACEUTICAL INGREDIENTSA61K 9/0056, A61K 9/2013, A61K 47/183, A61K 9/19, A61K 9/2018, A61K 9/2063, A61K 9/2095, A61K 31/165, A61K 31/403, A61K 31/426, A61K 31/5415, A61K 47/12, A61K 47/20, A61K 47/26, A61K 47/28, A61K 47/42Filed as Catalent U.K. Swindon Zydis Limited2024-05-10Ruba BNYAN | pending |
| EVA SEGMENTED INTRAVAGINAL RINGS CONTAINING PROGESTERONEA61F 6/08, A61K 9/0036, A61P 5/30, A61P 15/02, A61P 5/24, A61K 31/565, A61K 31/57, A61K 47/32, A61K 47/34, A61L 31/048, A61L 31/16, A61L2300/43Filed as JUNIPER PHARMACEUTICALS, INC. N/K/A CATALENT JNP, INC.2024-01-11Bridget Martell | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.